210 related articles for article (PubMed ID: 28154181)
1. USP39 Deubiquitinase Is Essential for
Fraile JM; Manchado E; Lujambio A; Quesada V; Campos-Iglesias D; Webb TR; Lowe SW; López-Otín C; Freije JM
J Biol Chem; 2017 Mar; 292(10):4164-4175. PubMed ID: 28154181
[No Abstract] [Full Text] [Related]
2. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
4. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
5. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
[TBL] [Abstract][Full Text] [Related]
6. The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor.
Zhu X; Ma J; Lu M; Liu Z; Sun Y; Chen H
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627203
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation.
Xiao Y; Ma W; Hu W; Di Q; Zhao X; Ma X; Chen X; Sun P; Wu H; Wu Z; Chen W
Mol Oncol; 2022 Jan; 16(2):388-404. PubMed ID: 33811456
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
9. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
Manrique I; Nguewa P; Bleau AM; Nistal-Villan E; Lopez I; Villalba M; Gil-Bazo I; Calvo A
Cancer Lett; 2015 Jan; 356(2 Pt B):899-909. PubMed ID: 25449776
[TBL] [Abstract][Full Text] [Related]
11. Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis.
Fritsche-Guenther R; Witzel F; Kempa S; Brummer T; Sers C; Blüthgen N
Oncotarget; 2016 Feb; 7(7):7960-9. PubMed ID: 26799289
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro.
Gan Z; Han K; Lin S; Hu H; Shen Z; Min D
Biol Res; 2017 Apr; 50(1):15. PubMed ID: 28403900
[TBL] [Abstract][Full Text] [Related]
13. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
14. Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer.
Dai X; Fan W; Wang Y; Huang L; Jiang Y; Shi L; Mckinley D; Tan W; Tan C
Mol Pharm; 2016 Feb; 13(2):520-33. PubMed ID: 26636714
[TBL] [Abstract][Full Text] [Related]
15. USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.
Zhao X; Wu X; Wang H; Yu H; Wang J
Mol Carcinog; 2020 Aug; 59(8):1000-1011. PubMed ID: 32511815
[TBL] [Abstract][Full Text] [Related]
16. The Deubiquitinase USP39 Promotes ESCC Tumorigenesis Through Pre-mRNA Splicing of the mTORC2 Component Rictor.
Zhao Y; Geng H; Liu G; Ji Q; Cheng X; Li X; Liu W; Thorne RF; Zhang R; Liu X
Front Oncol; 2021; 11():667495. PubMed ID: 34123832
[TBL] [Abstract][Full Text] [Related]
17. USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53.
Yuan J; Li X; Zhang Y; Zhang G; Cheng W; Wang W; Lei Y; Song G
Cell Biol Toxicol; 2023 Oct; 39(5):1995-2010. PubMed ID: 34822033
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of ubiquitin‑specific peptidase 39 inhibits the malignant progression of human renal cell carcinoma.
Xu Y; Zhu MR; Zhang JY; Si GM; Lv JJ
Mol Med Rep; 2018 Mar; 17(3):4729-4735. PubMed ID: 29328477
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Yan C; Yuan J; Xu J; Zhang G; Li X; Zhang B; Hu T; Huang X; Mao Y; Song G
Med Oncol; 2019 Oct; 36(11):95. PubMed ID: 31637536
[TBL] [Abstract][Full Text] [Related]
20. USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2.
Wu J; Chen Y; Geng G; Li L; Yin P; Nowsheen S; Li Y; Wu C; Liu J; Zhao F; Kim W; Zhou Q; Huang J; Guo G; Zhang C; Tu X; Gao X; Lou Z; Luo K; Qiao H; Yuan J
Cancer Lett; 2019 May; 449():114-124. PubMed ID: 30771428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
